Co-Delivery of Autoantigen and Dexamethasone in Incomplete Freund’s Adjuvant Ameliorates Experimental Autoimmune Encephalomyelitis

Current therapies for autoimmune diseases focus on treating the symptoms rather than the underlying disease cause. A major setback in improving current therapeutics for autoimmunity is the lack of antigen specificity. Successful antigen-specific immunotherapy (ASIT) would allow for improved treatmen...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:J Control Release
Autori principali: Northrup, Laura, Daniel Griffin, J., Christopher, Matthew A., Antunez, Lorena R., Hartwell, Brittany L., Pickens, Chad J., Berkland, Cory
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5723532/
https://ncbi.nlm.nih.gov/pubmed/28963036
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jconrel.2017.09.034
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi